Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
25,565,729
-
Share change
-
-4,415,532
-
Total reported value
-
$73,307,891
-
Put/Call ratio
-
40%
-
Price per share
-
$2.89
-
Number of holders
-
91
-
Value change
-
-$13,642,948
-
Number of buys
-
36
-
Number of sells
-
75
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2022
As of 30 Jun 2022,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,565,729 shares.
The largest 10 holders included
VANGUARD GROUP INC, Balyasny Asset Management LLC, Park West Asset Management LLC, BlackRock Inc., Laurion Capital Management LP, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, and Sio Capital Management, LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.